Your browser doesn't support javascript.
loading
Azulene hydrazide-hydrazones for selective targeting of pancreatic cancer cells.
Brogyányi, Tereza; Kaplánek, Robert; Kejík, Zdenek; Hosnedlová, Bozena; Antonyová, Veronika; Abramenko, Nikita; Veselá, Katerina; Martásek, Pavel; Vokurka, Martin; Richardson, Des R; Jakubek, Milan.
Afiliación
  • Brogyányi T; BIOCEV, First Faculty of Medicine, Charles University, Prague, Prumyslová 595, 252 50 Vestec, Czech Republic; Institute of Pathological Physiology, First Faculty of Medicine, Charles University and General University Hospital in Prague, U Nemocnice 5, 128 53 Prague, Czech Republic.
  • Kaplánek R; BIOCEV, First Faculty of Medicine, Charles University, Prague, Prumyslová 595, 252 50 Vestec, Czech Republic; Department of Paediatrics and Inherited Metabolic Disorders, First Faculty of Medicine, Charles University and General University Hospital in Prague, Ke Karlovu 455, 120 00 Prague, Czech Rep
  • Kejík Z; BIOCEV, First Faculty of Medicine, Charles University, Prague, Prumyslová 595, 252 50 Vestec, Czech Republic; Department of Paediatrics and Inherited Metabolic Disorders, First Faculty of Medicine, Charles University and General University Hospital in Prague, Ke Karlovu 455, 120 00 Prague, Czech Rep
  • Hosnedlová B; BIOCEV, First Faculty of Medicine, Charles University, Prague, Prumyslová 595, 252 50 Vestec, Czech Republic; Department of Paediatrics and Inherited Metabolic Disorders, First Faculty of Medicine, Charles University and General University Hospital in Prague, Ke Karlovu 455, 120 00 Prague, Czech Rep
  • Antonyová V; BIOCEV, First Faculty of Medicine, Charles University, Prague, Prumyslová 595, 252 50 Vestec, Czech Republic; Department of Paediatrics and Inherited Metabolic Disorders, First Faculty of Medicine, Charles University and General University Hospital in Prague, Ke Karlovu 455, 120 00 Prague, Czech Rep
  • Abramenko N; BIOCEV, First Faculty of Medicine, Charles University, Prague, Prumyslová 595, 252 50 Vestec, Czech Republic.
  • Veselá K; BIOCEV, First Faculty of Medicine, Charles University, Prague, Prumyslová 595, 252 50 Vestec, Czech Republic; Department of Paediatrics and Inherited Metabolic Disorders, First Faculty of Medicine, Charles University and General University Hospital in Prague, Ke Karlovu 455, 120 00 Prague, Czech Rep
  • Martásek P; Department of Paediatrics and Inherited Metabolic Disorders, First Faculty of Medicine, Charles University and General University Hospital in Prague, Ke Karlovu 455, 120 00 Prague, Czech Republic.
  • Vokurka M; Institute of Pathological Physiology, First Faculty of Medicine, Charles University and General University Hospital in Prague, U Nemocnice 5, 128 53 Prague, Czech Republic.
  • Richardson DR; Centre for Cancer Cell Biology and Drug Discovery, Griffith Institute for Drug Discovery, Griffith University, Nathan, Brisbane, QLD, Australia.
  • Jakubek M; BIOCEV, First Faculty of Medicine, Charles University, Prague, Prumyslová 595, 252 50 Vestec, Czech Republic; Department of Paediatrics and Inherited Metabolic Disorders, First Faculty of Medicine, Charles University and General University Hospital in Prague, Ke Karlovu 455, 120 00 Prague, Czech Rep
Biomed Pharmacother ; 155: 113736, 2022 Nov.
Article en En | MEDLINE | ID: mdl-36156366
Asunto(s)
Palabras clave
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Neoplasias Pancreáticas / Tiosemicarbazonas Límite: Humans Idioma: En Revista: Biomed Pharmacother Año: 2022 Tipo del documento: Article País de afiliación: República Checa
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Neoplasias Pancreáticas / Tiosemicarbazonas Límite: Humans Idioma: En Revista: Biomed Pharmacother Año: 2022 Tipo del documento: Article País de afiliación: República Checa